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The overall staining by GS clearly reveals 
astrocytes, including all cells of the astro-
glial family (1), i.e., Bergmann glia, Müller 
cells (2), tanycytes (3), and ependymal 
cells. The star shaped morphology from 
classical silver impregnations relates to 
cortical and hippocampal astrocytes, 
which display a comparable pattern in 
material stained for GFAP. However, the 
dense population of GS stained astro-
cytes found in all diencephalic and mes-
encephalic regions, known to display faint 
GFAP-labeling (unpublished observa-
tions) indicated that while apparently all 
astrocytes contain GS they have GFAP-ir 
filaments only in a region-dependent pat-
tern. This is complicated by the emerging 
view that “astrocytes” constitute a hetero-
geneous population even within a given 
region. In the rat hippocampus, combined 
immunostainings have revealed that the 
“classical” GFAP-ir astrocyte constitutes a 
subpopulation of GS-ir astrocytes, which 
can also lack GFAP staining [direct double 
staining (4)]. In view of several astroglial 
subtypes and/or glial precursors present 
in the adult rodent brain, anti-GS appears 
to be the most general astrocyte marker, 
covering all subtypes. In addition, GS 
has been found early on to label exclu-
sively astrocytic cells and no other glial 
or neuronal cell types in situ or in cul-
ture [reviewed by (5)]. GS has, thus, been 
applied as a reliable astrocyte marker in 
very many studies since.
“Complex cells” in rat hippocampus, 
initially assumed to be an astrocyte sub-
type (6) but now understood to belong to 
NG2 cells, a fourth glial type in the CNS 
(7), may display faint GS-ir in the soma 
but not its fine processes. Oligodendrocyte 
precursor cells, possibly also related to NG2 
cells, were found to be devoid of GS-ir (8). 
The immunocytochemical profile and 
possible  heterogeneity of NG2 cells is still 
under debate to date. Disputing the exclu-
sion of non-astrocytic cells in GS stain-
ing, some authors have later reported GS+ 
 oligodendrocytes, although this has not 
been investigated systematically. Reports 
on non-astrocytic GS will be discussed in 
detail here.
OligOdendrOcytes
The authors observing oligodendroglial 
GS localization rely mostly on the non-
convincing morphology of “ovoid cells” in 
the gray matter, and only sometimes on 
the unambiguous alignment of interfas-
cicular oligodendrocytes. Only one study 
is based on GS mRNA in situ hybridization 
(GS exclusively in astrocytes), and three 
studies on colocalization of GS-ir with 
oligodendroglial markers (see below). 
The reports on GS-ir in  oligodendrocytes 
by three groups (9–11) can, however, not 
be reconciled, and might result from the 
use of different antisera and/or divergent 
interpretations of morphology. Thus, 
Cammer (9), applying a proprietary anti-
sheep brain GS, observed clearly intra-
fascicular oligodendrocytes, but only 
faint white matter astrocytes in rat spi-
nal chord. A similar pattern was evident 
in rat forebrain white matter (propri-
etary GS antiserum; specimens prepared 
by Dr. M. Lavialle). Anti rat liver GS (9) 
produced the most convincing intrafas-
cicular oligodendrocytes displaying also 
immunoreactivity for CNPase, an estab-
lished oligodendrocyte marker. However, 
in gray matter, oligodendrocytes but 
hardly astrocytes were detectable by anti-
GS. Based on a different rabbit anti-sheep 
brain GS antiserum in cat brain, GS local-
ization was found in an inverse relation, 
i.e., only in gray matter oligodendrocytes 
but not interfascicular oligodendrocytes 
(10). These cells were  identified by light 
microscopic  morphological criteria, most 
of them in perineuronal position. A locali-
zation of GS in gray (but not white) mat-
ter  oligodendrocytes, mostly perineuronal 
and perivascular was confirmed by plausi-
ble ultrastructural criteria, using another 
 rabbit anti-sheep brain GS in the mouse 
brain (11). In this context, the absence of 
a typical light microscopical pattern distin-
guishing astrocytes from  oligodendrocytes 
in perineuronal position in cortex or hip-
pocampus, and generally in non-telen-
cephalic regions (where astrocytes are 
generally non-stellate) might be relevant. 
In these regions, the GS-ir gray matter 
oligodendrocytes observed by Miyake and 
Kitamura (11) were particularly abundant 
but “astrocytes” were hardly observed. 
GS-ir perineuronal oligodendrocytes were 
present in addition to astrocytes also in the 
cortex but not in the hippocampus, which 
would imply subclasses of perineuronal 
oligodendrocytes. Similarly, the figures 
provided by (10), of GS-ir gray matter 
 oligodendrocytes in the cortex (perineu-
ronal) and cerebellum (around Purkinje 
cells,) do not allow for clear differentia-
tion from astrocytes or Bergmann glia. 
This applies particularly to the cerebel-
lum where even an “oligodendrocyte-like 
astrocyte” has been described (12). In con-
trast, the GS-ir “ovoid cells” in the lizard 
mesencephalon were interpreted as astro-
cytic, since they were in alignment with 
radial glial fibers, and forming perivascu-
lar end feet (13). Non-astrocytic labeling 
by  anti-GS might also be associated with 
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 technical  difficulties. Thus, Werner et al. 
(14), although colocalizing GS with CNPase 
in oligodendrocytes, depict GS-ir in the 
nucleus or putative perinuclear cytoplasm, 
but not in processes. They also find positive 
microglia, which has never been reported 
before, and would normally represent a 
negative control. Similarly, in the report 
on GS staining in over 50% of CNPase 
positive perineuronal  oligodendrocytes 
(15), the GS-staining was not seen within 
the typical, ring-like CNPase+ cell rim (as 
clearly shown for several other markers in 
the same publication). Although apply-
ing confocal microscopy, the images show 
occasional 3D overlay of incongruent 
shapes in the two channels, which might 
lead to misinterpretation particularly since 
the authors did not consider neighboring, 
perineuronal astrocytes. In cell culture, 
where glial cell type purity and technical 
preparation may lead to diverging results, 
GS can be induced in cells that are nor-
mally not GS+, such as fibroblasts (16) 
or even chick brain neurons, which are 
GS− negative in vivo (17). GS induction in 
cultured oligodendrocytes, by corticoids or 
thyroid hormones was observed by some 
(18) but not others (17).
As evidence in favor of an astrocyte-
restricted GS localization [reviewed by 
(5)], absence of oligodendrocyte labeling 
in white and gray matter has been reported 
by the group of Norenberg, in particular 
at the ultrastructural level (19, 20), and 
the group of Derouiche, who investigated 
vibratome sections from human (21), and 
rat (3), using a previously characterized 
anti-GS antiserum (16) or commercial GS 
antibodies (Chemicon-Millipore, Billerica, 
MA, USA: clone GS-6, MAB 302; Santa 
Cruz Biotechnology, CA, USA, Ab: sc-6640; 
unpublished observations). In particular, 
GS-ir in the conspicuous interfascicular 
oligodendrocytes would not have been 
overlooked in the studies mentioned, and 
very many others. Based on distribution and 
morphology, localization of GS mRNA in 
rat brain, although without cell identifica-
tion, was in line with exclusive astrocytic 
labeling (22).
The clear distinction by GS-ir between 
astroglial cells and oligodendrocytes 
would be maintained in the tumors 
derived from these cells, since all astro-
cytomas and  ependymomas but none of 
the  oligodendrogliomas were GS+ (23). 
Another astrocytic antigen, ezrin, which 
labels  predominantly the fine, peripheral 
astrocyte processes of all astrocytic cells 
but not oligodendrocytes (24), has a cor-
responding, clear-cut specificity within the 
range of human glial tumors (25).
neurOns
Neuronal localization of GS has been 
undisputedly excluded by all studies, 
apart from two reports on human autoptic 
material from normal subjects, and indi-
viduals  suffering from Alzheimer’s disease 
(26, 27). In addition to astrocytes, the peri-
karya particularly of pyramidal cells were 
intensely labeled. Labeled neurons were 
observed in 2 (of 7) normal brains, and 
were highly variable in localization and 
quantity over cortical fields and layers also 
in all 10 cases from Alzheimer demented 
subjects (27). However, previous evidence 
and technical considerations suggest that 
these observations should be taken cum 
grano salis. Although there is no animal 
model for Alzheimer’s disease, neuronal 
localization has not been reported in any 
of the many experimental neuropathol-
ogy studies employing GS-ir. The finding 
also contrasts with previous human data 
(21) (4 cases), (23) (15), (28) (17). The 
only neuronal localization of GS in situ 
has been reported in a proteomic analysis 
of squid optic lobe synaptosomes, a defi-
nitely glia-free preparation (29). However, 
neuronal labeling similar to that reported 
(26, 27) has been observed in sections 
from rat brain (perfusion or immersion-
fixed, vibratome) or human hippocampus 
(vibratome, paraffin), applying vari-
ous anti-GS antisera in two laboratories 
(author’s unpublished observations; Dr. 
M. Lavialle, personal communication). 
This neuronal labeling was regarded as 
spurious, since it occurred inconsist-
ently after storage (exceeding 1 week), 
often without the expected glial staining, 
even in vibratome sections from the same 
block that has yielded the exclusive astro-
glial pattern in staining runs before. This 
might indicate the recognition of distinct 
epitopes displaying independent phys-
icochemical properties. Interestingly, the 
anti-GS mAb (Chemicon) also used by (27, 
28) has been found to cross reacts with a 
“GS-like protein” different from GS (30), 
however, its cellular localization in the 
brain has not been established.
subcellular gs lOcalizatiOn
Anti-GS has been found to represent an 
ultrastructural marker completely “fill-
ing” astrocytic cytoplasm in situ, well 
suited to mark also the extremely fine glial 
processes (20, 31). However, it was noted 
that labeling might also be associated with 
vesicles (5), which could not be verified in 
the stainings based on the diffusible chro-
mogen DAB (5). We further investigated 
this applying high-resolution fluorescence 
microscopy and deconvolution in primary 
astrocyte culture (32). Based on negative 
controls (Figures 1A–J), GS-ir using a 
polyclonal antibody made in rabbit (16) 
was  concentrated in discrete  structures 
 resembling vesicles (Figures 1K–O), 
which were also double-labeled applying 
different GS antibodies simultaneously 
(Figures 1K,N). Note that there is no full 
“colocalization,” i.e., full pixel superimpo-
sition of green and red channels. With the 
individual organelle as the unit of observa-
tion, however, the sparse, mostly incoherent 
pixels of the green channel [goat anti-GS 
(Santa Cruz sc-6640)] are mostly associated 
with the discrete, vesicle-like structures of 
the red channel (Figures 1K,N). This find-
ing, possibly resulting from differential 
labeling efficiencies of the antibodies, can 
be referred to as vesicular colocalization. 
These double-labeled vesicular structures 
were present throughout the cell but con-
centrated at limited stretches of the cell 
boundaries (arrows in Figures 1K,L, also 
in Figures 1E,H,J), they were frequently 
arranged in rows (arrows in Figures 1M,O), 
and their structure as far as could be 
resolved was non-uniform, pleomorph 
(Figures 1M,O).
While these observations do not neces-
sarily exclude the commonly assumed cyto-
solic presence of GS, they clearly suggest a 
vesicle-bound form. GS might be indirectly 
linked to vesicular membranes, as is known, 
e.g., from the glutamic acid decarboxylase 
isoform GAD65, which is attached to trans-
mitter vesicles via the vesicular GABA trans-
porter, to support neurotransmission (33). 
It will be interesting to further investigate 
whether these findings are important in 
the context of metabolic compartmenta-
tion, in particular in relation to glial gluta-
mate uptake, metabolism, and release (34). 
Similarly, how would the GS+ vesicles relate 
to those involved in vesicular exocytosis of 
glutamate from astrocytes?
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FigurE 1 | Continued
Organelle-bound localization of gS-immunoreactivity, in primary culture of 
rat cortical astrocytes using the following anti-gS antibodies: (1) polyclonal 
made in rabbit (15), or (2) goat (Santa Cruz sc-6640), or (3) mouse 
monoclonal (Chemicon-Millipore, Billerica, MA, uSA; clone gS-6, MAB 302). 
(A–J) Controls for double-labeling (red and green) with two anti-GS antibodies, red 
channel always in left, green in right column. (A,B) Control for autofluorescence, 
no immunoreagents. (C,D) Control for fluorescence red-to-green bleed through: 
Single staining anti-GS (1) with secondary anti-rabbit antibody (red). (E,F) Control 
for detection system of green channel: Same as in (C,D), in addition secondary 
anti-mouse antibody (green). (g,H) Control for fluorescence green-to-red bleed 
through: Single staining anti-GS (3) with secondary anti-mouse antibody (green). 
(i,J) control for detection system of red channel: Same as in (g,H), in addition 
anti-rabbit antibody (red). (K) Double-labeling by antibodies (1) and (2) coincides on 
the same organelles, even at high magnification [(N), from inset in (K)]. Antibody 
(1), red channel, labels the complete outline of organelles, whereas antibody (2), 
green channel only yields pixels within the extent of individual red labeled 
structures. Optical section 100 μm thick, after deconvolution. Single labeling by 
antibodies (3) (L) or (2) [(M,O), from inset] yields comparable organelles. Scale 
5 μm [in (J), for (A–J)], 3 μm (K,M), 4 μm (L), 0.25 μm (N), 0.5 μm (O).
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